Tyrosine phosphatase SHP-2 binding to CTLA-4: absence of direct YVKM/YFIP motif recognition

H Schneider1, C E Rudd

  • 1Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.

Insights

Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) signaling remains unclear. This study found that phosphorylated CTLA-4 tyrosines do not directly bind to the phosphatase SHP-2, suggesting an indirect interaction in T-cells.

Area of Science:

  • Immunology
  • Molecular Biology
  • Cell Signaling

Background:

  • Cytotoxic T-Lymphocyte-Associated protein 4 (CTLA-4) is a key regulator of T-cell activation and proliferation.
  • The precise intracellular signaling mechanisms by which CTLA-4 exerts its inhibitory functions are not fully understood.
  • CTLA-4 is known to interact with phosphatidylinositol 3-kinase (PI3K) and the phosphatase SHP-2.

Purpose of the Study:

  • To investigate the direct binding interaction between phosphorylated CTLA-4 and the SH2 domains of SHP-2.
  • To elucidate the role of specific tyrosine phosphorylation sites on CTLA-4 in mediating SHP-2 association.
  • To clarify the nature of the CTLA-4 and SHP-2 interaction in T-cells.

Main Methods:

  • Utilized in vitro binding assays with wild-type and mutant SHP-2 constructs (including isolated SH2 domains).
  • Investigated binding to phosphorylated CTLA-4 tyrosine motifs (YVKM and YFIP).
  • Confirmed CTLA-4 and SHP-2 association in murine T-cells.

Main Results:

  • Phosphorylation of CTLA-4 tyrosines at YVKM and YFIP motifs did not facilitate direct binding of SHP-2 SH2 domains.
  • Neither single nor tandem SHP-2 SH2 domains bound to the phosphorylated CTLA-4 motifs.
  • SHP-2 association with CTLA-4 was confirmed in T-cells, but appears to be an indirect event.

Conclusions:

  • The phosphorylated YVKM and YFIP motifs on CTLA-4 are unlikely to be direct binding sites for SHP-2.
  • The observed association between CTLA-4 and SHP-2 in T-cells is likely mediated indirectly, potentially involving PI3K.
  • Further research is needed to fully delineate the indirect signaling pathways connecting CTLA-4 and SHP-2.

Related Concept Videos

Assembly of Signaling Complexes01:30

Assembly of Signaling Complexes

Multiprotein signaling complexes are formed in a dynamic process involving protein-protein interactions at the cytoplasmic domain of transmembrane receptors or enzymatic and non-enzymatic proteins associated with the receptor. These complexes ensure the activation and propagation of intracellular signals that regulate cell functions.
Interaction domains in cell signaling
Interaction domains recognize exposed features of their binding partners containing post-translationally modified sequences,...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
T Cell Activation and Clonal Selection01:22

T Cell Activation and Clonal Selection

T cells are integral to our adaptive immune system, recognizing and effectively responding to foreign antigens. T cell activation and clonal selection are pivotal in orchestrating this immune response. This article elucidates these mechanisms, detailing the roles of cluster of differentiation (CD) markers, major histocompatibility complex (MHC) molecules, costimulatory signals, and the process of clonal selection.
Naive T cells that have not yet encountered an antigen express two primary CD...